tradingkey.logo

Hutchmed (China) Says Ipsen Initiates Market Withdrawal And Recall Of Tazverik In China

ReutersMar 9, 2026 5:12 PM

- HUTCHMED (China) Ltd 0013.HK:

  • IPSEN INITIATES MARKET WITHDRAWAL AND RECALL OF TAZVERIK IN CHINA

  • WITHDRAWS AND RECALLS TAZVERIK IN CHINA, HONG KONG, MACAU; ENDS ALL CLINICAL TRIALS

  • ІPSEN HAS INFORMED HUTCHMED THAT IT IS VOLUNTARILY WITHDRAWING TAZVERІK IN US

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI